Ledger.Open graph →

SEC Form D · filed September 26, 2018

BioAegis Therapeutics, Inc

Offering

$7.0M

Sold

$4.1M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

NORTH BRUNSWICK, NJ

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (7)

Jon D. Elias · Coral Gables, FLExec · Director Jarryd D. Levine · Greenwich, CTExec · Director Dana B. Mcgowan · San Diego, CAExec · Director David F. Hale · San Diego, CAExec · Director Brian B. Lannutti · San Diego, CAExec · Director Michael E. Coyle · San Ramon, CAExec · Director Mark Dinubile · North Brunswick, NJExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗